about
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. ...
Read More
1.61
0.00
(0.00%)
34,515
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for MetaVia Inc is on 20 Mar 2026 for the purpose of MetaVia Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
MetaVia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..